Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's expanding ...

Cannabis stocks are in focus today, with most of the action centered around U.S.-based multi-state operators (MSOs) after ...

The launch marks the first medical cannabis products Aphria RX has grown under the medical cannabis cultivation license ...

Medical, a division of Tilray Brands, announced the launch of its first commercial German grown medical cannabis flowers from its ...

Zuanic & Associates rates Tilray "Neutral," noting long-term potential but near-term uncertainties, despite cannabis growth ...

Shares of Tilray Brands Inc. TLRY shed 2.04% to $1.44 Wednesday, on what proved to be an all-around mixed trading session for ...

Blue Point Brewing Company, a subsidiary of Tilray Brands, announces Blitz Beer, a new American Lager added to Blue Point’s winter seasonal lineup. Available November through Fe ...

Tilray Medical, a division of ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners ...

Wealth Enhancement Advisory Services LLC increased its holdings in shares of Tilray Inc (NASDAQ:TLRY – Free Report) by 22.6% during the 3rd quarter, according to the company in its most recent 13F ...

NEW YORK, NY Nov. 14, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island’s original craft brewery and a ...

Tilray Brands Inc. is trying to trick investors for a second straight year into increasing its share limit, according to a lawsuit against the Canadian cannabis company.

The 5-year chart shows how much the sector has declined, though it is above the all-time low that was set a little over a year ago: I first wrote about Tilray here in April 2023, more than five ...